According to a report by Intel Market Research, the global Disease Diagnosis Antibody Testing Kits Market was valued at USD 934 million in 2025 and is estimated to reach USD 1.00 billion in 2026, before growing to USD 1.81 billion by 2034, representing a 7.6% CAGR during 2026–2034. Antibody testing kits serve centralized laboratories, epidemiological surveillance, point-of-care screening and selected self-testing pathways across infectious, autoimmune, oncology and allergy diagnostics. (Intel Market Research)

Explore the full report: Disease Diagnosis Antibody Testing Kits Market report

Why Is Demand Increasing?

• Persistent infectious-disease testing needs: UNAIDS reported 41.0 million people living with HIV in 2025, while WHO estimates 47 million people live with chronic hepatitis C globally. (Intel Market Research)

• Automation is reshaping laboratories: Siemens Healthineers' Atellica Integrated Automation is reported to reduce manual workflow steps by 75%, increasing demand for integrated analyzer and reagent ecosystems. (Intel Market Research)

• Decentralized testing is expanding: The report identifies point-of-care testing as a fast-expanding setting, supported by the regulatory pathway for selected self-tests and rapid formats. (Intel Market Research)

Diagnostics Technology & Decentralization Watch

The antibody testing Industry is moving simultaneously toward higher-throughput laboratory automation and more accessible decentralized testing. ELISA remains widely used because of its clinical familiarity and adaptability, while CLIA benefits from automation and broad analyzer menus. GICA and lateral-flow formats are increasingly relevant to community screening, point-of-care and selected self-testing applications. The report also highlights microfluidics, AI-supported analysis and advanced fluorescence or multiplex approaches as areas that can improve sensitivity, turnaround and specialty diagnostic capability. Regulatory developments are important to commercialization, with IVDR requirements shaping European portfolios and U.S. authorization creating pathways for selected at-home serology products. (Intel Market Research)

Segmentation Highlights

• By Technology: ELISA, CLIA, Colloidal Gold Immunochromatography, TRFIA and Other Immunoassays.

• Most Widely Used Technology: ELISA, supported by established clinical familiarity and economical batch testing. (Intel Market Research)

• By Application: Clinical Diagnosis, Epidemiological Investigation, Scientific Research, Health Management and Point-of-Care Testing.

• Leading Application: Clinical Diagnosis remains the largest application.

• By End User: Hospitals & Diagnostic Labs, Research Institutes, Pharmaceutical & Biotechnology Companies and Public Health Agencies.

• By Disease Type: Infectious Diseases, Autoimmune Diseases, Cancer, Allergies and Others. Infectious diseases hold the leading position. (Intel Market Research)

Regional Outlook

• North America is the largest regional market, representing more than 35% of global revenue in the underlying analysis. (Intel Market Research)

• Asia-Pacific is the fastest-growing region, supported by laboratory modernization, expanding hospital networks and local diagnostic manufacturing. (Intel Market Research)

• Europe is a mature market where IVDR conformity requirements increasingly influence portfolio economics.

• Brazil represents nearly half of South American demand in the report's regional analysis. (Intel Market Research)

Download the free sample report: Free Sample Report

Why This Market Matters

Antibody testing is becoming increasingly important across routine clinical diagnostics, public-health surveillance and decentralized screening. The market's commercial opportunity is not limited to infectious disease: autoimmune, oncology and allergy testing create specialized assay opportunities where specificity and clinical utility can support higher-value applications.

The competitive structure also favors suppliers that can operate across different diagnostic environments. Large companies can leverage installed analyzer ecosystems and recurring reagent demand, while regional manufacturers can compete through rapid formats, localized menus and cost-efficient testing. (Intel Market Research)

Competitive Landscape

• Roche Diagnostics — Leads the supplier landscape with an 18% share of 2024 market revenue in the report analysis.

• Abbott Laboratories — Competes through high-throughput immunoassay platforms and broad disease menus.

• Siemens Healthineers — Competes through automation, immunoassay platforms and hospital-laboratory integration.

• Thermo Fisher Scientific — Participates through broad diagnostics and life-science capabilities.

• Danaher Corporation — Competes through diversified diagnostics, assay breadth and global capabilities. (Intel Market Research)

View the full report: Full Disease Diagnosis Antibody Testing Kits Market Report

FAQ

Q: What is the Disease Diagnosis Antibody Testing Kits Market size and forecast?
A: The market was valued at USD 934 million in 2025, estimated at USD 1.00 billion in 2026 and projected to reach USD 1.81 billion by 2034 at a 7.6% CAGR. (Intel Market Research)

Q: Which regions lead the market?
A: North America is the largest region, while Asia-Pacific is the fastest-growing. (Intel Market Research)

Q: Which disease segment leads the market?
A: Infectious diseases are the leading disease segment, supported by screening, exposure assessment and diagnostic requirements across conditions including HIV, hepatitis and syphilis. (Intel Market Research)

What Does the Full Report Cover?

The full report provides deeper Market Size, Share, Growth and Forecast analysis across antibody-testing technologies, applications, end users and disease categories. It examines ELISA, CLIA, GICA, TRFIA and other immunoassays alongside clinical diagnosis, epidemiological investigation, research, health management and point-of-care testing. Regional analysis covers North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, with selected country developments. The study also evaluates laboratory automation, self-testing, regulatory requirements, IVDR transition, assay validation, public-health procurement and decentralized testing. Competitive profiles examine global diagnostics platforms and regional manufacturers, including their technology positioning, analyzer ecosystems, assay breadth and market-access strategies. (Intel Market Research)

View the complete report: Complete Disease Diagnosis Antibody Testing Kits Market Report

Download the free sample: Download Free Sample

Related Reports

No related IMR report URLs were provided on the supplied source page, so no unverified links have been added.

About Intel Market Research

Intel Market Research provides strategic market intelligence, forecasts, competitive analysis and industry research across healthcare, medical devices, diagnostics and related markets.

Contact Details

Website: www.intelmarketresearch.com | Asia-Pacific: +91 9169164321